524 related articles for article (PubMed ID: 10427351)
1. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Deleu D; Hanssens Y
Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
[TBL] [Abstract][Full Text] [Related]
2. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
Deleu D; Hanssens Y
J Clin Pharmacol; 2000 Jul; 40(7):687-700. PubMed ID: 10883409
[TBL] [Abstract][Full Text] [Related]
3. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
Goldstein D
Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
[No Abstract] [Full Text] [Related]
4. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
Mathew NT; Kailasam J; Gentry P; Chernyshev O
Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042
[TBL] [Abstract][Full Text] [Related]
5. Building on the sumatriptan experience: the development of naratriptan.
Connor HE
Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
[No Abstract] [Full Text] [Related]
6. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
[TBL] [Abstract][Full Text] [Related]
7. [Highly selective beginning. Associated symptoms and side effects in retrospect].
MMW Fortschr Med; 2003 May; 145 Suppl 2():107. PubMed ID: 14579499
[No Abstract] [Full Text] [Related]
8. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
Ashcroft DM; Millson D
Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068
[TBL] [Abstract][Full Text] [Related]
9. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
[TBL] [Abstract][Full Text] [Related]
10. Looking forward: the expanding utility of sumatriptan and naratriptan.
Cady R
Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821
[No Abstract] [Full Text] [Related]
11. Acute management of migraine: triptans and beyond.
Diener HC; Limmroth V
Curr Opin Neurol; 1999 Jun; 12(3):261-7. PubMed ID: 10499171
[TBL] [Abstract][Full Text] [Related]
12. Comparative aspects of triptans in treating migraine.
Adelman JU; Lewit EJ
Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316
[TBL] [Abstract][Full Text] [Related]
13. [Zolmitriptan].
Monseu G; Sternon J
Rev Med Brux; 1998 Dec; 19(6):495-9. PubMed ID: 9916496
[TBL] [Abstract][Full Text] [Related]
14. Triptans to the rescue: effective therapy for migraine headaches in the workplace.
Bartleson JD
Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229
[No Abstract] [Full Text] [Related]
15. Correlation between lipophilicity and triptan outcomes.
Pascual J; Muñoz P
Headache; 2005 Jan; 45(1):3-6. PubMed ID: 15663606
[TBL] [Abstract][Full Text] [Related]
16. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
[TBL] [Abstract][Full Text] [Related]
17. Acute treatment of migraine and the role of triptans.
Freitag FG
Curr Neurol Neurosci Rep; 2001 Mar; 1(2):125-32. PubMed ID: 11898508
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of 5HT in migraine.
Buzzi MG
Cephalalgia; 1999 Sep; 19(7):625-6. PubMed ID: 10524654
[No Abstract] [Full Text] [Related]
19. Naratriptan: an alternative for migraine.
Dulli DA
Ann Pharmacother; 1999 Jun; 33(6):704-11. PubMed ID: 10410185
[TBL] [Abstract][Full Text] [Related]
20. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
Limmroth V; Kazarawa Z; Fritsche G; Diener HC
Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
[No Abstract] [Full Text] [Related]
[Next] [New Search]
